Functional Interaction of E1AF and Sp1 in Glioma Invasion

REFERENCES

• Albini, A., Y. Iwamoto, H. K. Kleinman, G. R. Martin, S. A. Aaronson, J. M. Kozlowski, and R. N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239–3245.
   PubMed Web of Science ®Google Scholar
• Azizkhan, J. C., D. E. Jensen, A. J. Pierce, and M. Wade. 1993. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 3:229–254.
   PubMedGoogle Scholar
• Bachoo, R. M., E. A. Maher, K. L. Ligon, N. E. Sharpless, S. S. Chan, M. J. You, Y. Tang, J. DeFrances, E. Stover, R. Weissleder, D. H. Rowitch, D. N. Louis, and R. A. DePinho. 2002. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1:269–277.
   PubMed Web of Science ®Google Scholar
• Baert, J. L., C. Beaudoin, L. Coutte, and Y. de Launoit. 2002. ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain. J. Biol. Chem. 277:1002–1012.
   PubMed Web of Science ®Google Scholar
• Bailly, R. A., R. Bosselut, J. Zucman, F. Cormier, O. Delattre, M. Roussel, G. Thomas, and J. Ghysdael. 1994. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14:3230–3241.
   PubMed Web of Science ®Google Scholar
• Black, A. R., J. D. Black, and J. Azizkhan-Clifford. 2001. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 188:143–160.
   PubMed Web of Science ®Google Scholar
• Black, A. R., D. Jensen, S. Y. Lin, and J. C. Azizkhan. 1999. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 274:1207–1215.
   PubMed Web of Science ®Google Scholar
• Bosselut, R., J. Levin, E. Adjadj, and J. Ghysdael. 1993. A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74. Nucleic Acids Res. 21:5184–5191.
   PubMed Web of Science ®Google Scholar
• Chen, X., J. Jiang, J. Yang, C. Chen, M. Sun, Y. Wei, X. Guang, and J. Gu. 2006. Down-regulation of the expression of β1,4-galactosyltransferase V promotes integrin β1 maturation. Biochem. Biophys. Res. Commun. 343:910–916.
   PubMedGoogle Scholar
• Chu, S., and T. J. Ferro. 2005. Sp1: regulation of gene expression by phosphorylation. Gene 348:1–11.
   PubMed Web of Science ®Google Scholar
• DeAngelis, L. M. 2001. Brain tumors. N. Engl. J. Med. 344:114–123.
   PubMed Web of Science ®Google Scholar
• Dittmer, J., A. Gegonne, S. D. Gitlin, J. Ghysdael, and J. N. Brady. 1994. Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1. J. Biol. Chem. 269:21428–21434.
   PubMedGoogle Scholar
• Firlej, V., B. Bocquet, X. Desbiens, Y. de Launoit, and A. Chotteau-Lelievre. 2005. Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site. J. Biol. Chem. 280:887–898.
   PubMedGoogle Scholar
• Gartel, A. L., E. Goufman, F. Najmabadi, and A. L. Tyner. 2000. Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene 19:5182–5188.
   PubMedGoogle Scholar
• Gonzalez, M. I., and D. M. Robins. 2001. Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1. J. Biol. Chem. 276:6420–6428.
   PubMedGoogle Scholar
• Guo, S., T. Sato, K. Shirane, and K. Furukawa. 2001. Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 11:813–820.
   PubMed Web of Science ®Google Scholar
• Hakuma, N., I. Kinoshita, Y. Shimizu, K. Yamazaki, K. Yoshida, M. Nishimura, and H. Dosaka-Akita. 2005. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res. 65:10776–10782.
   PubMed Web of Science ®Google Scholar
• Hanzawa, M., M. Shindoh, F. Higashino, M. Yasuda, N. Inoue, K. Hida, M. Ono, T. Kohgo, M. Nakamura, K. Notani, H. Fukuda, Y. Totsuka, K. Yoshida, and K. Fujinaga. 2000. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21:1079–1085.
   PubMed Web of Science ®Google Scholar
• Jaishankar, S., J. Zhang, M. F. Roussel, and S. J. Baker. 1999. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity. Oncogene 18:5592–5597.
   PubMedGoogle Scholar
• Jiang, J., X. Chen, J. Shen, Y. Wei, T. Wu, Y. Yang, H. Wang, H. Zong, J. Yang, S. Zhang, J. Xie, X. Kong, W. Liu, and J. Gu. 2006. β1,4-Galactosyltransferase V functions as a positive growth regulator in glioma. J. Biol. Chem. 281:9482–9489.
   PubMedGoogle Scholar
• Kavurma, M. M., Y. Bobryshev, and L. M. Khachigian. 2002. Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1. J. Biol. Chem. 277:36244–36252.
   PubMed Web of Science ®Google Scholar
• Kurpios, N. A., N. A. Sabolic, T. G. Shepherd, G. M. Fidalgo, and J. A. Hassell. 2003. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 8:177–190.
   PubMedGoogle Scholar
• Ladle, D. R., and E. Frank. 2002. The role of the ETS gene PEA3 in the development of motor and sensory neurons. Physiol. Behav. 77:571–576.
   PubMedGoogle Scholar
• Lai, J. S., and W. Herr. 1992. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl. Acad. Sci. USA 89:6958–6962.
   PubMed Web of Science ®Google Scholar
• Laing, M. A., S. Coonrod, B. T. Hinton, J. W. Downie, R. Tozer, M. A. Rudnicki, and J. A. Hassell. 2000. Male sexual dysfunction in mice bearing targeted mutant alleles of the PEA3 ets gene. Mol. Cell. Biol. 20:9337–9345.
   PubMedGoogle Scholar
• Lee, J. A., D. C. Suh, J. E. Kang, M. H. Kim, H. Park, M. N. Lee, J. M. Kim, B. N. Jeon, H. E. Roh, M. Y. Yu, K. Y. Choi, K. Y. Kim, and M. W. Hur. 2005. Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J. Biol. Chem. 280:28061–28071.
   PubMedGoogle Scholar
• Li, M., and R. E. Kellems. 2003. Sp1 and Sp3 are important regulators of AP-2γ gene transcription. Biol. Reprod. 69:1220–1230.
   PubMedGoogle Scholar
• Liedtke, C., N. Groger, M. P. Manns, and C. Trautwein. 2003. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 278:27593–27604.
   PubMed Web of Science ®Google Scholar
• O'Hagan, R. C., and J. A. Hassell. 1998. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene 16:301–310.
   PubMed Web of Science ®Google Scholar
• O'Hagan, R. C., R. G. Tozer, M. Symons, F. McCormick, and J. A. Hassell. 1996. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13:1323–1333.
   PubMedGoogle Scholar
• Pang, R. T., L. T. Lee, S. S. Ng, W. H. Yung, and B. K. Chow. 2004. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Mol. Endocrinol. 18:471–483.
   PubMedGoogle Scholar
• Pore, N., S. Liu, H. K. Shu, B. Li, D. Haas-Kogan, D. Stokoe, J. Milanini-Mongiat, G. Pages, D. M. O'Rourke, E. Bernhard, and A. Maity. 2004. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell 15:4841–4853.
   PubMed Web of Science ®Google Scholar
• Saluja, D., M. F. Vassallo, and N. Tanese. 1998. Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators. Mol. Cell. Biol. 18:5734–5743.
   PubMed Web of Science ®Google Scholar
• Santiago, F. S., and L. M. Khachigian. 2004. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Circ. Res. 95:479–487.
   PubMedGoogle Scholar
• Sato, T., and K. Furukawa. 2004. Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1. J. Biol. Chem. 279:39574–39583.
   PubMedGoogle Scholar
• Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
   PubMed Web of Science ®Google Scholar
• Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2:827–837.
   PubMed Web of Science ®Google Scholar
• Shepherd, T. G., L. Kockeritz, M. R. Szrajber, W. J. Muller, and J. A. Hassell. 2001. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr. Biol. 11:1739–1748.
   PubMed Web of Science ®Google Scholar
• Shindoh, M., F. Higashino, and T. Kohgo. 2004. E1AF, an ets-oncogene family transcription factor. Cancer Lett. 216:1–8.
   PubMedGoogle Scholar
• Sowa, Y., T. Orita, S. Minamikawa, K. Nakano, T. Mizuno, H. Nomura, and T. Sakai. 1997. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241:142–150.
   PubMed Web of Science ®Google Scholar
• Subbaramaiah, K., L. Norton, W. Gerald, and A. J. Dannenberg. 2002. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J. Biol. Chem. 277:18649–18657.
   PubMed Web of Science ®Google Scholar
• Subramanian, C., and E. S. Robertson. 2002. The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription. J. Virol. 76:8702–8709.
   PubMedGoogle Scholar
• Tonn, J. C., and R. Goldbrunner. 2003. Mechanisms of glioma cell invasion. Acta Neurochir. Suppl. 88:163–167.
   PubMedGoogle Scholar
• Xie, R. L., S. Gupta, A. Miele, D. Shiffman, J. L. Stein, G. S. Stein, and A. J. van Wijnen. 2003. The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter. J. Biol. Chem. 278:26589–26596.
   PubMedGoogle Scholar
• Xu, S., S. Zhang, C. Chen, J. Yan, M. Cai, X. Zhu, and J. Gu. 2002. Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line. J. Exp. Clin. Cancer Res. 21:409–414.
   PubMedGoogle Scholar
• Xu, S., X. Zhu, S. Zhang, S. Yin, L. Zhou, C. Chen, and J. Gu. 2001. Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma. J. Cancer Res. Clin. Oncol. 127:502–506.
   PubMed Web of Science ®Google Scholar
• Yan, G. Z., and E. B. Ziff. 1997. Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci. 17:6122–6132.
   PubMed Web of Science ®Google Scholar
• Yan, S., I. M. Berquin, B. R. Troen, and B. F. Sloane. 2000. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. DNA Cell Biol. 19:79–91.
   PubMed Web of Science ®Google Scholar
• Zhu, X., S. Chen, X. Yin, A. Shen, S. Ji, Z. Shen, and J. Gu. 2003. Constitutively active PKB/Akt inhibited apoptosis and down-regulated beta1,4-galactosyltransferase 1 in hepatocarcinoma cells. Biochem. Biophys. Res. Commun. 309:279–285.
   PubMedGoogle Scholar
• Zhu, X., J. Jiang, H. Shen, H. Wang, H. Zong, Z. Li, Y. Yang, Z. Niu, W. Liu, X. Chen, Y. Hu, and J. Gu. 2005. Elevated β1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. J. Biol. Chem. 280:12503–12516.
   PubMed Web of Science ®Google Scholar